TearLab Corp. said it will delist from the Toronto Stock Exchange, effective March 29, subject to approval from the regulator.
The San Diego-based diagnostics company said it will be unable to regain compliance with TSX's continued listing requirements by the March 29 deadline.
The company said its stock will remain listed on the OTCQB under the symbol TEAR.
TearLab said the costs associated with maintaining a dual listing were "no longer justified" while the company works toward conserving resources and streamlining its operations.
In November 2017, the company said it would delist its securities from the Nasdaq Capital Market due to continued noncompliance with the exchange's listing requirements.
